Skipping the newborn vitamin K shot tripled the odds of brain bleeding

What happens to babies who do not get the vitamin K shot at birth?

They bleed more. In a Swedish study of 2,020,302 births, infants who skipped the newborn vitamin K shot had 1.5 times the odds of a bleeding episode and nearly 3 times the odds of bleeding inside the brain. In absolute terms, brain bleeds went from about 1 in 1,580 babies who got the shot to about 1 in 454 who did not, so the risk stays low either way and still nearly triples without it.

The vitamin K shot is one of the oldest and quietest pieces of newborn care. A nurse gives it in the thigh within an hour or two of birth, most parents barely notice, and then nothing happens. Nothing happening is the entire point. This study is what the “nothing” looks like when you take it away, measured across nearly every baby born in Sweden over 19 years.

Babies are born with very little vitamin K. Their bodies cannot make it yet, they get almost none through the placenta, and breast milk carries only small amounts. Vitamin K is what lets blood clot. Without it, a newborn can bleed from the gut, the umbilical stump, or, in the worst cases, inside the skull, sometimes days or weeks after leaving the hospital, and sometimes with no warning sign at all. A single shot at birth loads up the reserve and closes that window.

What the data show

Researchers followed 2,020,302 live births in Sweden from 2003 through 2021. Among them, 24,089 infants did not get the intramuscular vitamin K shot, which is a little over 1 percent of all babies.

Those infants bled more often. After adjusting for other differences between families, the odds of a bleeding episode were 1.52 times higher in babies who missed the shot. For intracranial hemorrhage, meaning bleeding inside the skull, the odds were 2.91 times higher, close to a tripling.

What that looks like in absolute terms

Those multipliers are the headline, but they are not the number a parent actually needs. Here is what the study counted in the first six months of life.

Any bleeding diagnosis:

Babies who got the shot: 7,570 events among 1,996,213 infants, or 380 per 100,000. That is about 1 in 263.
Babies who did not: 153 events among 24,089 infants, or 636 per 100,000. That is about 1 in 157.

Bleeding inside the skull:

Babies who got the shot: 1,265 events, or 63 per 100,000. That is about 1 in 1,580.
Babies who did not: 53 events, or 220 per 100,000. That is about 1 in 454.

So the absolute difference for brain bleeding is roughly 157 extra events per 100,000 babies. Put another way, for every 640 or so newborns who skip the shot, you would expect about one additional bleed inside the skull that the shot would likely have prevented. The 2.91 odds ratio and that one-in-640 figure are two descriptions of the same finding: the ratio tells you how much the risk multiplies, the absolute numbers tell you how big the risk was to begin with. Both are true, and quoting only the first one, in either direction, misleads.

The base risk here is low, and the shot is a large part of why. A near tripling of a small number is still a small number. It is also, in this case, 53 real infants with blood inside the skull, most of whom would not have been there had they received a dose that takes a few seconds to give and carries no serious known harm. That is the trade the shot is asking you to make.

One technical note, since I am quoting both kinds of numbers. The study reports odds ratios, not risk ratios. When an outcome is rare, as it is here, the two are nearly identical, so reading 2.91 as “close to three times the risk” is fair. That approximation breaks down for common outcomes, which is why it matters that this one is rare.

The trend line is the part that worries me most. Non-receipt of the shot dropped to a low of 0.66 percent of births in 2006. Since then it has more than doubled, reaching 1.50 percent by 2021. A risk that medicine had almost completely erased is slowly walking back into the nursery.

Dr. Kumar’s Take

I operate on brains for a living, so intracranial hemorrhage is not an abstraction to me. A bleed inside an infant skull is one of the few problems where the difference between a normal life and a catastrophic one can come down to hours. And this one is preventable with a shot that costs almost nothing and takes seconds.

What strikes me here is how invisible the benefit is. Parents who decline the shot usually watch their baby go home healthy, and that feels like proof they made the right call. The babies who were protected also go home healthy, so the two look identical from the outside. The harm only shows up when you can count two million births at once, which is exactly what Sweden’s registries let these researchers do. That is the whole value of a study like this: it makes a rare, hidden risk visible.

I will be honest about what this study cannot tell us. It is observational, not a randomized trial. Families who decline the vitamin K shot may differ in other ways, including other choices about newborn care, and the researchers can only adjust for the differences they can measure. But the size of the effect on brain bleeding, the biological mechanism, and the fact that this matches decades of prior evidence all point in the same direction.

Why the numbers are climbing

Refusal is rising in a lot of countries, not just Sweden, and the reasons tend to be familiar. Some parents worry about giving a “chemical” to a brand new baby. Some prefer the oral form, which requires multiple doses over weeks and works less reliably, especially if a dose is spit up or forgotten. Some are simply told, by a source they trust, that it is optional.

The problem is that this is not the kind of decision you get to revisit. Late vitamin K deficiency bleeding can appear weeks after birth in a baby who looked perfectly healthy. By the time there are symptoms, the bleeding has already started.

Practical Takeaways

Accept the intramuscular vitamin K shot for your newborn, since it is a single dose given at birth and this study links skipping it to nearly triple the odds of bleeding inside the brain.
Keep both kinds of numbers in view when you weigh the decision, because the risk of a brain bleed rose from about 1 in 1,580 babies with the shot to about 1 in 454 without it, which is a near tripling of a risk that is small either way.
If you are considering the oral form instead, discuss it directly with your pediatrician, because it requires a full course of repeated doses over several weeks and any missed dose leaves a gap in protection.
Ask your birth hospital or midwife ahead of time how they administer vitamin K, so the decision is made deliberately rather than in the first chaotic hour after delivery.
Know that bleeding from vitamin K deficiency can appear weeks after a healthy discharge, so an uneventful first few days at home is not evidence that the risk has passed.

FAQs

Why can’t a baby just get vitamin K from breast milk?

Breast milk is close to perfect for a newborn in almost every respect, but vitamin K is the exception. It contains only small amounts, and a baby’s gut bacteria, which help produce vitamin K later in life, have not established themselves yet in the first weeks. This is not a flaw in breastfeeding and it is not a reason to stop. It simply means the one nutrient breast milk is thin on has to come from somewhere else, and the shot is the most reliable way to provide it.

Is the oral form of vitamin K a reasonable alternative?

It is better than nothing, but it is not equivalent. The shot is a single dose that creates a reserve the baby draws on for months. Oral vitamin K requires several doses spread over weeks, and it depends on the baby absorbing it properly and on the parents completing the schedule. A spit-up dose, a missed appointment, or an undiagnosed liver or gut condition that impairs absorption all create gaps. If you are strongly opposed to the injection, talk to your pediatrician about the oral schedule rather than skipping vitamin K entirely.

Does an adjusted odds ratio of 2.91 mean my baby has a 3 in 10 chance of a brain bleed?

No, and this is a common misreading. An odds ratio compares two groups, it does not describe your baby’s absolute chance. What 2.91 means is that among babies who did not get the shot, brain bleeds occurred close to three times as often as among babies who did. The absolute chance in this study was about 220 per 100,000 without the shot, or roughly 1 in 454, against 63 per 100,000, roughly 1 in 1,580, with it. Tripling a small risk still leaves a small risk, but it is a small risk of a devastating and largely avoidable event.

If the absolute risk is that low, is the shot really worth it?

That is the right question to ask, and it comes down to what you are trading. The cost of the shot is a few seconds of discomfort and no serious known harm. The benefit is preventing roughly one brain bleed for every 640 babies who would otherwise skip it. Most interventions in medicine ask you to accept meaningful side effects for a modest chance of benefit. This one asks for almost nothing and removes a rare event whose consequences, when it does happen, can be permanent. A low absolute risk is an argument for calm, not for skipping the shot.

Bottom Line

Across two million Swedish births, infants who did not receive the intramuscular vitamin K shot had 1.52 times the odds of a bleeding episode and 2.91 times the odds of bleeding inside the skull. In absolute terms that is 220 brain bleeds per 100,000 unprotected babies against 63 per 100,000 protected ones, so roughly one extra bleed for every 640 newborns who skip the dose. Both numbers matter: the risk stays low in absolute terms, and it still nearly triples for no good reason. Meanwhile, the share of babies going without the shot has more than doubled since 2006, from 0.66 percent to 1.50 percent. This is a preventable harm quietly rebuilding itself, one declined shot at a time, and the fix is a single injection in the first hour of life.

Read the full study